Agilent has developed a new microarray-based application for studying microRNAs (miRNAs) that combines a unique miRNA direct labeling method with our innovative probe design and established high-performance SurePrint inkjet synthesis technology. miRNA is the latest addition to our integrated and comprehensive repertoire of proven genomics tools. The creation of complete miRNA expression profiles using robust and highly sensitive microarrays allows you to be the first to gain broad insight into human miRNA expression and regulation. This new capability is a unique opportunity to develop a confident and clear picture of the intricate expression networks and systems that impact your genomics research.
This document describes the Agilent Human miRNA Microarray Kit, which utilizes a unique direct labeling method and proprietary SurePrint inkjet synthesis technology. The platform is designed to provide high sensitivity and specificity for studying microRNA expression and regulation in human samples, particularly for cancer research applications.
| Total features | ~ 15,000 |
|---|---|
| Starting sample input | 100 ng total RNA |
| Detection limit | less than 0.1 amol |
| Sequence source | Sanger miRBASE Release 9.1 |
The kit requires 100 ng of total RNA.
The system can detect synthetic miRNAs at concentrations less than 0.1 amol.
The microarray contains approximately 15,000 features.